OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dr Namir Hassan will be meeting the Oxford Pharmacology Society to discuss his reflections on his career journey to date, his knowledge and experience in large pharma and small biotech, his thoughts on key elements of success and his perspective on growth areas in science. Namir Hassan joined Zelluna Immunotherapy in August 2018 to serve as Chief Scientific Officer and as Chief Executive Officer since Jan 2020. He has over 15 years of biotech and pharma industry experience from target validation through to early phase clinical trials.
